|
|||
Scanalytics Announces Collaborative Research and Development Agreement with the Naval Medical Research CenterSix-Month Study to Refine IPLab Elispot Imager for Use in Immunological Research Studies (FAIRFAX, VA - August 23, 1999) Scanalytics, Inc., a developer of imaging software and systems for biotechnology and life sciences applications, today announced a Collaborative Research and Development Agreement (CRADA) with the Naval Medical Research Center (NMRC), Department of the Navy. The research agreement is the basis of a six-month study to enhance the capabilities of Scanalytics’ IPLab Elispot Imager™ system to complement NMRC’s innovative anti-malaria strategies. Further enhancements to the system are aimed at making it more flexible and expandable to accommodate other imaging and analysis applications. The study will focus on the characterization of protein expression by enzyme linked immunospot (Elispot) assays. As a part of the agreement, Scanalytics has an option to negotiate an exclusive license with NMRC for inventions that arise from the CRADA research. "We believe the collaboration with NMRC on enhancements to our IPLab Elispot Imager product will result in a system with a broader range of applications for imaging technologies in immunological research." stated Michael Mort, Ph.D., President of Scanalytics. Features of Elispot Assays and IPLab Elispot Imager For more detailed information on IPLab Elispot Imager, contact Scanalytics' Sales Department at 703-208-2230 or email us at info@scanalytics.com. |
|||
|
Copyright © 2006 by BD Biosciences Bioimaging 301-340-7320 |